Activation of focal adhesion kinase and JNK contributes to the extracellular matrix and cAMP-GEF mediated survival from bile acid induced apoptosis in rat hepatocytes

Journal of Hepatology

Volumn 49, Issue 2, 2008, Pages 251-261

  Usechak, Paul ^a   Gates, Anna ^a   Webster, Cynthia RL ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Bile acids; cAMP GEF; Collagen; Exchange protein regulated by cAMP (EPAC); Extracellular matrix; Focal adhesion kinase; JNK; Laminin; Phosphoinositide 3 kinase (PI3K); Polylysine

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BILE ACID; COLLAGEN TYPE 1; CYCLIC AMP; CYTOCHALASIN B; DEOXYCHOLIC ACID; FAS LIGAND; FOCAL ADHESION KINASE; GLYCOCHENODEOXYCHOLIC ACID; GUANINE DERIVATIVE; GUANINE EXCHANGE FACTOR; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PHOSPHOSPECIFIC ANTIBODY; POLYLYSINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; IMMUNOBLOTTING; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BILE ACIDS AND SALTS; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN TYPE I; CYCLIC AMP; EXTRACELLULAR MATRIX; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HEPATOCYTES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LAMININ; POLYLYSINE; RATS;

EID: 46149092240     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.04.015     Document Type: Article

References (51)

1. Smets F.N., Yongming C., Ling-Jia W., and Soriano H. Loss of cell anchorage triggers apoptosis (anoikis) in primary mouse hepatocytes. Mol Gen Metab 75 (2002) 344-352
2. Pinkse G.G.M., Jiawan-Lalai R., Bruijn J., and deHeer E. RGD peptides confer survival to hepatocytes via the b1-integrin-ILK-pAkt pathway. J Hepatol 42 (2005) 87-93
3. Pinske G.G.M., Voorhoeve M.P., Noteborn M., Terpstra O.T., Bruijn J.A., and de Heer E. Hepatocyte survival depends on α 1 integrin mediated attachment of hepatocytes to hepatic extracellular matrix. Liver Inter 24 (2004) 218-226
4. Hosiba T., Nagahara H., Cho C.-S., and Tagawa Y-I Akaike T. Primary hepatocyte survival on non-integrin recognizable matrices without the activation of Akt. Biomaterials 28 (2007) 1093-1104
5. Qiao L., and Farrel G. The effects of cell density, attachment substratum and dexamethasone on spontaneous apoptosis of rat hepatocytes in primary culture. In Vitro Cell Dev Biol 35 (1999) 417-424
6. Martinez-Hernandez A. The hepatocellular matrix II: Electron immunohistochemical studies in rats with CCl4 induced cirrhosis. Lab Invest 53 (1985) 166-186
7. Martinez-Hernandez A. The hepatic extracellular matrix I: Electron immunohistochemical studies in normal rat liver. Lab Invest 51 (1984) 57-74
8. Zeitlin L., Resnick M.S., Konikoff F., Schuppan D., Bujanover Y., Lerner A., et al. Divergent patterns of extracellular matrix protein expression in neonatal versus adult liver fibrosis. Pediatr Pathol Mol Med 22 (2003) 349-362
9. Matsumoto S., Yamamoto K., Nagano T., Okamoto R., Ibuki N., Tagashira M., et al. Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition. Liver 19 (1999) 32-38
10. Desmouliere A., Darby I., Costa A.M., Raccurt M., Tuchweber B., Sommer P., et al. Extracellular matrix deposition, lysyl oxidase expression and myofibroplastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest 76 (1997) 765-778
11. Volpes R., van den Oord J.J., and Desmet V.J. Distribution of the VLA family of integrins in normal and pathologic liver tissue. Gastroenterology 101 (1991) 200-206
12. Arnaout M.A., Goodman S.L., and Xiong J.P. Structure and mechanics of integrin-based cell adhesion. Curr Opin Cell Biol 19 (2007) 495-507
13. Mitra S.K., and Schlaepfer D.D. Integrin-regulated FAK-src signaling in normal and cancer cells. Curr Opin Cell Biol 18 (2006) 516-523
14. van Nimwegen M.J., and van de Water B. Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 73 (2007) 597-609
15. Chiorean M.V., Guicciardi M.E., Yoon J.H., Bronk S.F., Kaufmanns S.H., and Gores G.J. Imatinib mesylate induces apoptosis in human cholangiocarcinoma cells. Liver Int 24 (2004) 687-695
16. Fang Y., Wang L., Jin J., and Zha X. Focal adhesion kinase affects the sensitivity of human hepatocellular carcinoma cell line SMMC-7721 to tumor necrosis factor a/cycloheximide induced apoptosis by regulating protein kinase B levels. Eur J Biochem 268 (2001) 4513-4519
17. Higuchi H., and Gores G.J. Bile acid regulation of hepatic physiology IV: Bile acids and death receptors. Am J Physiol Gastrointest Liver Physiol 284 (2003) G734-G738
18. Schoemaker M.H., Gommans W.M., Conde de la Rosa L., Homan M., Klok P., Trautwein C., et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol 39 (2003) 153-161
19. Mitchell C., Park M.A., Zhang G., Han S.I., Harada H., Franklin R.A., et al. 17-Allylamino-17-demethoxygeldanamycin enhances the lethality of deoxycholic acid in primary rodent hepatocytes and established cell lines. Mol Cancer Ther 6 (2007) 618-632
20. Grambihler A., Higuchi H., Bronk S.F., and Gores G.J. cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acid-mediated apoptosis. J Biol Chem 278 (2001) 26831-26837
21. Haussinger D., Kurz A.K., Wettstein M., Graf D., Vom Dahl S., and Schliess F. Involvement of integrins and Src in tauroursodeoxycholate induced and swelling induced choleresis. Gastroenterology 124 (2003) 1476-1487
22. Khare S., Holgren C., and Samarel A.M. Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2. Am J Physiol Gastrointest Liver Physiol 291 (2006) G1100-G1112
23. Webster C.R.L., Usechek P., and Anwer M.S. cAMP inhibits bile acid induced apoptosis by blocking caspase activation and cytochrome C release. Am J Physiol Gastrointest Liver Physiol 283 (2002) G727-G738
24. Graf D., Reinehr R., Kurz A.K., Fischer R., and Haussinger D. Inhibition of taurolithocholate 3-sulfate induced apoptosis by cyclic AMP in rat hepatocytes involves protein kinase A-dependent and independent mechanisms. Arch Biochem Biophys 425 (2003) 34-42
25. Cullen K., McCool J., Anwer M.S., and Webster C.R.L. Activation of cAMP-guanine exchange factor (cAMP-GEF) confers protein kinase A independent protection from hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol 287 (2004) G334-G343
26. Bos J.L. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 31 (2006) 680-686
27. Holz G.G., Kang G., Harbeck M., Roe M.W., and Chepurny O.G. Cell physiology of cAMP sensor Epac. J Physiol 577 (2006) 5-15
28. Hansen L., Mooney D., Vacanti J., and Ingber D. Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol Biol Chem 5 (1994) 967-975
29. Schoemaker M.H., Conde de la Rosa L., Buist-Homan M., Vrenken T.E., Havinga R., Poelstra K., et al. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39 (2004) 1563-1573
30. Chen C.S., Mrksich M., Huang S., Whitesides G.M., and Ingber D.E. Geometric control of cell life and death. Science 276 (1997) 1425-1428
31. Bissell D.M., Stamatoglou S.C., Nermut M.V., and Hughes C. Interactions of rat hepatocytes with type IV collagen, fibronectin and laminin matrices. Eur J Cell Biol 40 (1986) 72-78
32. Wary K.K., Dans M., Mariotti A., and Giancotti F.G. Biochemical analysis of integrin-mediated Shc signaling. Methods Mol Biol 129 (1999) 35-49
33. Bouchard V., Demers M.J., Thibodeau S., Laquerre V., Fujita N., Tsuruo T., et al. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J Cell Physiol 212 (2007) 717-728
34. Harnois C., Demers M.J., Bouchard V., Vallee K., Gagne D., Fujita N., et al. Human intestinal epithelial crypt cell survival and death: complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways. J Cell Physiol 198 (2004) 209-222
35. Barberis L., Wary K.K., Fiucci G., Liu F., Hirsch F., Brancaccio M., et al. Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK. J Biol Chem 275 (2000) 36532-36540
36. Hirano F., Haneda M., and Makino I. Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes. J Gastroenterol Hepatol 21 (2006) 1807-1813
37. Wu Y., Nan L., Bardag-Gorce F., Li J., French B.A., Wilson L.T., et al. The role of laminin-integrin signaling in triggering MB formation. An in vivo and in vitro study. Exp Mol Pathol 79 (2005) 1-8
38. Fujii T., Koshikawa K., Nomoto S., Okochi O., Kaneko T., Inoue S., et al. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. J Hepatol 41 (2004) 104-111
39. Jean-Louis S., Akare S., Ali M.A., Mash Jr. E.A., Meuillet E., and Martinez J.D. Deoxycholic acid induces intracellular signaling through membrane perturbations. J Biol Chem 281 (2006) 14948-14960
40. Fickert P., Trauner M., Fuchsbichler A., Stumptner C., Zatloukal K., and Denk H. Cytokeratins as targets for bile acid induced toxicity. Am J Pathol 160 (2002) 491-499
41. Tuchweber B., Roy S., Desroches S., Yousef I.M., Gicquad C., Weber A.M., et al. Effects of bile acids on actin polymerization in vitro. Life Sci 47 (1990) 1299-1307
42. Thibault N., Maurice M., Maratrat M., Cordier A., Feldman G., and Ballet F. Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated hepatocyte couplets. J Hepatol 19 (1993) 367-376
43. Thamilselvan V., Craig D.H., and Basson M.D. FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J 21 (2007) 1730-1741
44. Montiel M., de la Blanca E.P., and Jimenez E. Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells. Biochem Biophys Res Commun 25;327 (2005) 971-978
45. Amaral J.D., Castro R.E., Solá S., Steer C.J., and Rodrigues C.M. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. J Biol Chem 282 (2007) 34250-34259
46. Castro R.E., Amaral J.D., Solá S., Kren B.T., Steer C.J., and Rodrigues C.M. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes. Am J Physiol Gastrointest Liver Physiol 293 (2007) G327-G334
47. Shaker A.M. Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications. Curr Opin Chem Biol 6 (2002) 534-554
48. Shimaoka M., and Springer T.A. Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov 2 (2003) 703-716
49. Li J., Tan H., Dong X., Xu Z., Shi C., Han X., et al. Antisense integrin alphaV and beta3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas. Dig Liver Dis 39 (2007) 557-565
50. Patsenker E., Popov Y., Wiesner M., Goodman S.L., and Schuppan D. Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. J Hepatol 46 (2007) 878-887
51. Shi Q, Hjelmeland AB, Keir ST, Song L, Wickman S, Jackson D, et. al. A novel low molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth Mol Carcinog 2007;46: 488-496.